Abstract
The cell-surface structures of Neisseria meningitidis play a critical role in the interaction of the bacterium with the human host both as variable antigens that evade immune eradication and by promoting colonization of and adherence to epithelial cells in the nasopharynx. Surface molecules are also implicated in the patho- genicity of some meningococci by facilitating invasion of host cells, survival in the bloodstream, and resistance to phagocytosis. The antigenic diversity among cell- surface components has also been exploited for the development of classification schemes for N. meningitidis, which have in turn been used for epidemiological monitoring of meningococcal disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eldridge J., Sutcliffe E. M., Abbott J. D., and Jones D.M. (1978) Serological grouping of meningococci and detection of antigen in cerebrospinal fluid by coagglutination. Med. Lab. Sci. 35, 63ā66.
Davis D. M., Dulbecco R., Eisen H. N., and Ginsberg H. S. (1980) The Neisseriae, in Microbiology (Gotschlich E. C., ed.), Harper, New York, NY, pp. 635ā644.
Goldschneider I., Gotschlich E. C., and Artenstein M. S. (1969) Human Immunity to the Meningococcus. II. Development of Natural Immunity. J. Exp. Med. 129, 1327ā1348.
Jennings H. J. and Lugowski C. (1981) Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127, 1011ā1018.
Costantino P., Viti S., Podda A., Velmonte M. A., Nencioni L., and Rappuoli R. (1992) Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine 10, 691ā698.
Richmond P., Goldblatt D., Fusco P. C., Fusco J. D., Heron I., Clark S., Borrow R., and Michon F. (1999) Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 18,641ā646.
Campagne G., Garba A., Fabre P., Schuchat A., Ryall R., Boulanger D., et al. (2000) Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger. Pediatr. Infect. Dis. J. 19, 144ā150.
Frosch M., Weisgerber C., and Meyer T. F. (1989) Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc. Natl. Acad. Sci. USA 86, 1669ā1673.
Edwards U., Muller A., Hammerschmidt S., Gerardy-Schahn R., and Frosch M. (1994) Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol. Microbiol. 14, 141ā149.
Swartley J. S., Marfin A. A., Edupuganti S., Liu L. J., Cieslak P., Perkins B., et al. (1997) Capsule switching of Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 94, 271ā276.
Maiden M. C. J. and Spratt B. G. (1999) Meningococcal conjugate vaccines: new opportunities and new challenges. Lancet 354,615ā616.
Stephens D. S., Spellman P. A., and Swartley J. S. (1993) Effect of the (alpha 2ā8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J. Infect. Dis. 167,475ā479.
Hammerschmidt S., Muller A., Sillmann H., Muhlenhoff M., Borrow R., Fox A., et al. (1996) Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol. 20, 1211-1120.
Hammerschmidt S., Hilse R., van Putten J. P., Gerardy-Schahn R., Unkmeir A., and Frosch M. (1996) Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 15, 192ā198.
Heckels J. E. (1989) Structure and function of pili of pathogenic Neisseria species. Clin. Microbiol. Rev. 2S, S66āS73.
Virji M., Saunders J. R., Sims G., Makepeace K., Maskell D., and Ferguson D. J. P. (1993) Pilus-facilitated adherence of Neisseria meningitidis to human epithelial and endothelial cells: modulation of adherence phenotype occurrs concurrently with changes in primary amino acid sequence and the glycosylation status of pilin.Mol. Microbiol. 10, 1013ā1028.
Virji M., Kayhty H., Ferguson D. J., Alexandrescu C., Heckels J. E., and Moxon E. R. (1991) The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol. Microbiol. 5, 1831ā1841.
McLeod Griffiss J. (1995) Mechanisms of host immunity, in Meningococcal Disease (Cartwright K. A. V., ed.), John Wiley and Sons, Chichester, UK, pp. 35ā70.
Poolman J. T., van der Ley P. A., and Tommassen J. (1995) Surface structures and secreted products of meningococci, in Meningococcal Disease (Cartwright K. A. V., ed.), John Wiley and Sons, Chichester, UK, pp. 21ā34.
Hart C. A. and Rogers T. R. F. (1993) Meningococcal disease. J. Med. Microbiol. 39, 3ā25.
Virji M., Alexandrescu C., Ferguson D.J., Saunders J.R., and Moxon E.R. (1992) Variations in the expression of pili: the effect on adherence of Neisseria meningitidis to human epithelial and endothelial cells. Mol. Microbiol. 6,1271ā1279.
Nassif X., Lowy J., Stenberg P., OāGaora P., Ganji A., and So M. (1993) Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells. Mol. Microbiol. 8, 719ā725.
de Vries F. P., van der Ende A., van Putten J. P., and Dankert J. (1996) Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect. Immun. 64,2998ā3006.
Legrain M., Mazarin V., Irwin S. W., Bouchon B., Quentin Millet M. J., Jacobs E., and Schryvers A. B. (1993) Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene 130, 73ā80.
Cornelissen C. N., Kelley M., Hobbs M. M., Anderson J. E., Cannon J. G., Cohen M. S., and Sparling P. F. (1998) The transferrin receptor expressed by gonococcal strain FA 1090 is required for the experimental infection of human male volunteers. Mol. Microbiol. 27,611ā616.
Lissolo L., Maitre Wilmotte G., Dumas P., Mignon M., Danve B., and Quentin Millet M. J. (1995) Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect. Immun. 63, 884ā890.
Schryvers A. B. and Stojiljkovic I. (1999) Iron acquisition systems in the pathogenic Neisseria. Mol. Microbiol. 32,1117ā1123.
Dyer D. W., West E. P., McKenna W., Thompson S. A., and Sparling P. F. (1988) A pleiotropic iron-uptake mutant of Neisseria meningitidis lacks a 70-kilodalton iron-regulated protein. Infect. Immun. 56,977ā983.
Carson S. D. B., Klebba P. E., Newton S. M. C., and Sparling P. F. (1999) Ferric enterobactin binding and utilisation by Neisseria gonorrhoeae. J. Bacteriol. 181,2895ā2901.
Thulasiraman P., Newton S. M. C., Xu J., Raymond K. N., Mai C., Hall A., et al. (1998) Selectivity of ferric enterobactin binding and cooperativity of transport in Gram-negative bacteria. J. Bacteriol. 180, 6689ā6696.
Pettersson A., Maas A., van Wassenaar D., van der Ley P., and Tommassen J. (1995) Molecular characterization of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis. Infect. Immun. 63,4181ā4184.
van der Ley P., van der Biezen J., Sutmuller R., Hoogerhout P., and Poolman J. T. (1996) Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae. Microbiology 142, 3269ā3274.
Tsai C.-M., Frasch C. E., and Mocca L. F. (1981) Five structural classes of major outer membrane proteins in Neisseria meningitidis. J. Bacteriol. 146,69ā78.
Barlow A. K., Heckels J. E., and Clarke I. N. (1989) The class 1 outer membrane protein of Neisseria meningitidis: gene sequence and structural and immunological similarities to gonococcal porins. Mol. Microbiol. 3, 131ā139.
Virji M. (1996) Meningococcal disease: epidemiology and pathogenesis. Trends Microbiol. 4,466ā469.
Virji M., Makepeace K., Ferguson D. J., Achtman M., and Moxon E. R. (1993) Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol. Microbiol. 10,499ā510.
Virji M., Makepeace K., Ferguson D. J. P., Achtman M., Sarkari J., and Moxon E. R. (1992) Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis. Mol. Microbiol. 6, 2785ā2795.
van der Ley P., Heckels J. E., Virji M., Hoogerhout P., and Poolman J. T. (1991) Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59,2963ā2971.
Sarkari J., Pandit N., Moxon E. R., and Achtman M. (1994) Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promotor containing poly-cytidine. Mol. Microbiol. 13,207ā217.
Hitchcock P. J. (1989) Unified nomenclature for pathogenic Neisseria species. Clin. Microbiol. Rev. 2, S64āS65.
van der Ende A., Hopman C. T. P., Zaat S., Oude Essink B. B., Berkhout B., and Dankert J. (1995) Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the-10 and-35 regions of the promoter. J. Bacteriol. 177, 2475ā2480.
Derrick J. P., Urwin R., Suker J., Feavers I. M., and Maiden M. C. J. (1999) Structural and evolutionary inference from molecular variation in Neisseria porins. Infect. Immun. 67,2406ā2413.
Frasch C. E., Zollinger W. D., and Poolman J. T. (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7, 504ā510.
Saukkonen K., Leinonen M., Abdillahi H., and Poolman J.T. (1989) Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 7, 325ā328.
Maiden M. C. J., Suker J., McKenna A. J., Bygraves J. A., and Feavers I. M. (1991) Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol. Microbiol. 5, 727ā736.
Bash M. C., Lesiak K. B., Banks S. D., and Frasch C. E. (1995) Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques. Infect. Immun. 63,1484ā1490.
Smith N. H., Maynard Smith J., and Spratt B. G. (1995) Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. Mol. Biol. Evol. 12, 363ā370.
Urwin R. (1998) PhD Thesis: Variation in Meningococcal PorB Proteins. University of Staffordshire, Stoke-on-Trent, UK.
Suker J., Feavers I. M., and Maiden M. C. J. (1996) Monoclonal antibody recognition of members of the P1. 10 variable region family: implications for serological typing and vaccine design. Microbiology 142,63ā69.
Urwin R., Fox A. J., Musilek M., Kriz P., and Maiden M. C. J. (1998) Heterogeneity of the PorB protein in serotype 22 Neisseria meningitidis. J. Clin. Microbiol. 36, 3680ā3682.
Urwin R., Feavers I. M., Jones D. M., Maiden M. C. J., and Fox A. J. (1998) Molecular variation of meningococcal serotype 4 antigen genes. Epidemiol. Infect. 121,95ā101.
Bygraves J. A., Urwin R., Fox A. J., Gray S. J., Russell J. E., Feavers I. M., and Maiden M. C. J. (1999) Population genetic and evolutionary approaches to the analysis of Neisseria meningitidis isolates belonging to the ET-5 complex. J. Bacteriol. 181, 5551ā5556.
Embley T. M. (1991) The linear PCR reaction: a simple and robust method for sequencing amplified rRNA genes. Lett. Appl. Microbiol. 13,171ā174.
Sanger F., Nicklen S., and Coulson A. R. (1977) DNA sequencing with chainterminating inhibitors. Proc. Nat. Acad. Sci. USA 74,5463ā5467.
Staden R. (1996) The Staden sequence analysis package. Mol. Biotechnol. 5, 233ā241.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Urwin, R. (2001). Nucleotide Sequencing of Antigen Genes of Neisseria meningitidis . In: Walker, J.M., Pollard, A.J., Maiden, M.C.J. (eds) Meningococcal Disease. Methods in Molecular Medicineā¢, vol 67. Humana Press. https://doi.org/10.1385/1-59259-149-3:157
Download citation
DOI: https://doi.org/10.1385/1-59259-149-3:157
Publisher Name: Humana Press
Print ISBN: 978-0-89603-849-3
Online ISBN: 978-1-59259-149-7
eBook Packages: Springer Protocols